SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Stealth Peptides Inc. Completes Initial Phase I Clinical Trial Cohort with BendaviaTM, a Mitochondrial Targeted Therapy for Ischemia Reperfusion Injury